UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Glioblastoma survival in the United States improved after Food and Drug Administration approval of bevacizumab: A population‐based analysis

Cancer, 2013-10, Vol.119 (19), p.3489-3495

2013

Volltextzugriff (PDF)

IDH-wild-type glioblastoma cell density and infiltration distribution influence on supramarginal resection and its impact on overall survival: a mathematical model

Journal of neurosurgery, 2022-06, Vol.136 (6), p.1567-1575

2022

Volltextzugriff (PDF)

Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial

Nature communications, 2024-01, Vol.15 (1), p.493-493, Article 493

2024

Volltextzugriff (PDF)

Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients

Journal of neurosurgery, 2013-04, Vol.118 (4), p.786-798

2013

Volltextzugriff (PDF)

Treatment of Glioma in the 21st Century: An Exciting Decade of Postsurgical Treatment Advances in the Molecular Era

Mayo Clinic proceedings, 2017-06, Vol.92 (6), p.995-1004

2017

Volltextzugriff (PDF)

Prevalence and characteristics of central nervous system involvement by chronic lymphocytic leukemia

Haematologica (Roma), 2016-04, Vol.101 (4), p.458-465

2016

Volltextzugriff (PDF)

Central Nervous System Tumors

Mayo Clinic proceedings, 2007-10, Vol.82 (10), p.1271-1286

2007

Volltextzugriff (PDF)

Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177

Journal of clinical oncology, 2008-12, Vol.26 (34), p.5603-5609

2008

Volltextzugriff (PDF)

Phase II Evaluation of Gefitinib in Patients With Newly Diagnosed Grade 4 Astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074

International journal of radiation oncology, biology, physics, 2011-06, Vol.80 (2), p.347-353

2011

Volltextzugriff (PDF)

North Central Cancer Treatment Group Phase I Trial N057K of Everolimus (RAD001) and Temozolomide in Combination With Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme

International journal of radiation oncology, biology, physics, 2011-10, Vol.81 (2), p.468-475

2011

Volltextzugriff (PDF)

Galectin-1, a gene preferentially expressed at the tumor margin, promotes glioblastoma cell invasion

Molecular cancer, 2012-05, Vol.11 (1), p.32-32, Article 32

2012

Volltextzugriff (PDF)

Recurrent papillary craniopharyngioma with BRAF V600E mutation treated with dabrafenib: case report

Journal of neurosurgery, 2019-04, Vol.130 (4), p.1299-1303

2019

Volltextzugriff (PDF)

Belzutifan in adults with VHL-associated central nervous system hemangioblastoma: a single-center experience

Journal of neuro-oncology, 2023-08, Vol.164 (1), p.239-247

2023

Volltextzugriff (PDF)

A case series of osseous metastases in patients with glioblastoma

Medicine (Baltimore), 2024-07, Vol.103 (27), p.e38794

2024

Volltextzugriff (PDF)

Neuro-oncology: Implications of the molecular era

Neurology, 2019-03, Vol.92 (12), p.568-574

2019

Volltextzugriff (PDF)

Phase II Study of Bevacizumab in Combination with Sorafenib in Recurrent Glioblastoma (N0776): A North Central Cancer Treatment Group Trial

Clinical cancer research, 2013-09, Vol.19 (17), p.4816-4823

2013

Volltextzugriff (PDF)

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Emerging Therapies for the Treatment of Patients With Vestibular Schwannomas

Neurosurgery, 2018-02, Vol.82 (2), p.E52-E54

2018

Volltextzugriff (PDF)

A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K

Neuro-oncology (Charlottesville, Va.), 2015-09, Vol.17 (9), p.1261-1269

2015

Volltextzugriff (PDF)

Management and Long-term Outcomes of Adults With Medulloblastoma: A Single-Center Experience

Neurology, 2023-09, Vol.101 (12), p.e1256

2023

Volltextzugriff (PDF)

Clinical, Neurophysiologic, and Pathologic Features in Patients With Early-Onset Postradiation Neuropathy

Neurology, 2023-10, Vol.101 (14), p.e1455

2023

Volltextzugriff (PDF)

Predicting access to postoperative treatment after glioblastoma resection: an analysis of neighborhood-level disadvantage using the Area Deprivation Index (ADI)

Journal of neuro-oncology, 2022-07, Vol.158 (3), p.349-357

2022

Volltextzugriff (PDF)

Management and Long-Term Outcomes of Patients With Recurrent Stroke-Like Episodes After Cranial Radiotherapy

The Neurologist (Baltimore, Md.), 2023-07, Vol.28 (4), p.218-225

2023

Volltextzugriff (PDF)

Overall survival in patients with glioblastoma before and after bevacizumab approval

Current medical research and opinion, 2018-05, Vol.34 (5), p.813-820

2018

Volltextzugriff (PDF)

Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma

World neurosurgery, 2017-07, Vol.103, p.655-663

2017

Volltextzugriff (PDF)

Panobinostat in adults with H3 K27M-mutant diffuse midline glioma: a single-center experience

Journal of neuro-oncology, 2022-03, Vol.157 (1), p.91-100

2022

Volltextzugriff (PDF)

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(124)
Mit Volltextzugriff
(116)

Publikationsform

Artikel
(129)
Tagungsberichte
(1)

Sprache

Englisch
(130)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Glioblastoma survival in the United States improved after Food and Drug Administration approval of bevacizumab: A population‐based analysis

IDH-wild-type glioblastoma cell density and infiltration distribution influence on supramarginal resection and its impact on overall survival: a mathematical model

Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial

Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients

Treatment of Glioma in the 21st Century: An Exciting Decade of Postsurgical Treatment Advances in the Molecular Era

Prevalence and characteristics of central nervous system involvement by chronic lymphocytic leukemia

Central Nervous System Tumors

Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177

Phase II Evaluation of Gefitinib in Patients With Newly Diagnosed Grade 4 Astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074

North Central Cancer Treatment Group Phase I Trial N057K of Everolimus (RAD001) and Temozolomide in Combination With Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme

Galectin-1, a gene preferentially expressed at the tumor margin, promotes glioblastoma cell invasion

Recurrent papillary craniopharyngioma with BRAF V600E mutation treated with dabrafenib: case report

Belzutifan in adults with VHL-associated central nervous system hemangioblastoma: a single-center experience

A case series of osseous metastases in patients with glioblastoma

Neuro-oncology: Implications of the molecular era

Phase II Study of Bevacizumab in Combination with Sorafenib in Recurrent Glioblastoma (N0776): A North Central Cancer Treatment Group Trial

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Emerging Therapies for the Treatment of Patients With Vestibular Schwannomas

A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K

Management and Long-term Outcomes of Adults With Medulloblastoma: A Single-Center Experience

Clinical, Neurophysiologic, and Pathologic Features in Patients With Early-Onset Postradiation Neuropathy

Predicting access to postoperative treatment after glioblastoma resection: an analysis of neighborhood-level disadvantage using the Area Deprivation Index (ADI)

Management and Long-Term Outcomes of Patients With Recurrent Stroke-Like Episodes After Cranial Radiotherapy

Overall survival in patients with glioblastoma before and after bevacizumab approval

Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma

Panobinostat in adults with H3 K27M-mutant diffuse midline glioma: a single-center experience

Suchergebnisse filtern